#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=5. Adipose Tissue Inflammation
1-1	0-2	5.	_	_	_	_
1-2	3-10	Adipose	abstract|object[2]|abstract[3]	new|new[2]|new[3]	coref|coref|coref	3-1|3-1[6_2]|3-15[9_3]
1-3	11-17	Tissue	object[2]|abstract[3]	new[2]|new[3]	_	_
1-4	18-30	Inflammation	abstract[3]	new[3]	_	_

#Text=during Aging
2-1	31-37	during	_	_	_	_
2-2	38-43	Aging	abstract	new	coref	4-1

#Text=Adipose tissue plays an essential role in age-related metabolic dysfunction and is linked to systemic , chronic , and low-grade inflammation .
3-1	44-51	Adipose	abstract|object[6]	giv|giv[6]	coref|coref	5-1[16_6]|5-26
3-2	52-58	tissue	object[6]	giv[6]	_	_
3-3	59-64	plays	_	_	_	_
3-4	65-67	an	abstract[7]	new[7]	_	_
3-5	68-77	essential	abstract[7]	new[7]	_	_
3-6	78-82	role	abstract[7]	new[7]	_	_
3-7	83-85	in	abstract[7]	new[7]	_	_
3-8	86-97	age-related	abstract[7]|abstract[8]	new[7]|new[8]	coref	11-12[101_8]
3-9	98-107	metabolic	abstract[7]|abstract[8]	new[7]|new[8]	_	_
3-10	108-119	dysfunction	abstract[7]|abstract[8]	new[7]|new[8]	_	_
3-11	120-123	and	_	_	_	_
3-12	124-126	is	_	_	_	_
3-13	127-133	linked	_	_	_	_
3-14	134-136	to	_	_	_	_
3-15	137-145	systemic	abstract[9]	giv[9]	coref	4-18[14_9]
3-16	146-147	,	abstract[9]	giv[9]	_	_
3-17	148-155	chronic	abstract[9]	giv[9]	_	_
3-18	156-157	,	abstract[9]	giv[9]	_	_
3-19	158-161	and	abstract[9]	giv[9]	_	_
3-20	162-171	low-grade	abstract[9]	giv[9]	_	_
3-21	172-184	inflammation	abstract[9]	giv[9]	_	_
3-22	185-186	.	_	_	_	_

#Text=Aging is associated with a decline in immune competence referred to as immunosenescence , which leads to chronic , low-grade inflammation named “ inflammaging ” .
4-1	187-192	Aging	abstract	giv	coref	9-6
4-2	193-195	is	_	_	_	_
4-3	196-206	associated	_	_	_	_
4-4	207-211	with	_	_	_	_
4-5	212-213	a	event[11]	new[11]	_	_
4-6	214-221	decline	event[11]	new[11]	_	_
4-7	222-224	in	event[11]	new[11]	_	_
4-8	225-231	immune	event[11]|abstract[12]	new[11]|new[12]	_	_
4-9	232-242	competence	event[11]|abstract[12]	new[11]|new[12]	_	_
4-10	243-251	referred	event[11]	new[11]	_	_
4-11	252-254	to	event[11]	new[11]	_	_
4-12	255-257	as	event[11]	new[11]	_	_
4-13	258-274	immunosenescence	event[11]|abstract[13]	new[11]|new[13]	coref	5-47[0_13]
4-14	275-276	,	event[11]|abstract[13]	new[11]|new[13]	_	_
4-15	277-282	which	event[11]|abstract[13]	new[11]|new[13]	_	_
4-16	283-288	leads	event[11]|abstract[13]	new[11]|new[13]	_	_
4-17	289-291	to	event[11]|abstract[13]	new[11]|new[13]	_	_
4-18	292-299	chronic	event[11]|abstract[13]|abstract[14]	new[11]|new[13]|giv[14]	coref	5-1[17_14]
4-19	300-301	,	event[11]|abstract[13]|abstract[14]	new[11]|new[13]|giv[14]	_	_
4-20	302-311	low-grade	event[11]|abstract[13]|abstract[14]	new[11]|new[13]|giv[14]	_	_
4-21	312-324	inflammation	event[11]|abstract[13]|abstract[14]	new[11]|new[13]|giv[14]	_	_
4-22	325-330	named	event[11]|abstract[13]|abstract[14]	new[11]|new[13]|giv[14]	_	_
4-23	331-332	“	event[11]|abstract[13]|abstract[14]	new[11]|new[13]|giv[14]	_	_
4-24	333-345	inflammaging	event[11]|abstract[13]|abstract[14]|abstract	new[11]|new[13]|giv[14]|new	_	_
4-25	346-347	”	event[11]|abstract[13]|abstract[14]	new[11]|new[13]|giv[14]	_	_
4-26	348-349	.	_	_	_	_

#Text=Adipose tissue inflammation results in the release of pro-inflammatory cytokines such as TNF-α , IL-1b , IL-6 and monocyte chemoattractant protein ( MCP-1/CCL2 ) from adipose tissue macrophages , and these factors are also associated to the presence of senescent cells ( p16INK4A ) leading to immunosenescence .
5-1	350-357	Adipose	object[16]|abstract[17]	giv[16]|giv[17]	coref|coref	5-26[28_16]|6-27[0_17]
5-2	358-364	tissue	object[16]|abstract[17]	giv[16]|giv[17]	_	_
5-3	365-377	inflammation	abstract[17]	giv[17]	_	_
5-4	378-385	results	_	_	_	_
5-5	386-388	in	_	_	_	_
5-6	389-392	the	event[18]	new[18]	_	_
5-7	393-400	release	event[18]	new[18]	_	_
5-8	401-403	of	event[18]	new[18]	_	_
5-9	404-420	pro-inflammatory	event[18]|abstract[19]	new[18]|new[19]	coref	6-8[0_19]
5-10	421-430	cytokines	event[18]|abstract[19]	new[18]|new[19]	_	_
5-11	431-435	such	event[18]|abstract[19]	new[18]|new[19]	_	_
5-12	436-438	as	event[18]|abstract[19]	new[18]|new[19]	_	_
5-13	439-444	TNF-α	event[18]|abstract[19]|abstract	new[18]|new[19]|new	coref	8-31
5-14	445-446	,	event[18]|abstract[19]	new[18]|new[19]	_	_
5-15	447-452	IL-1b	event[18]|abstract[19]|abstract	new[18]|new[19]|new	_	_
5-16	453-454	,	event[18]|abstract[19]	new[18]|new[19]	_	_
5-17	455-459	IL-6	event[18]|abstract[19]|abstract	new[18]|new[19]|new	coref	8-26
5-18	460-463	and	event[18]|abstract[19]	new[18]|new[19]	_	_
5-19	464-472	monocyte	event[18]|abstract[19]|object|substance[25]	new[18]|new[19]|new|new[25]	coref	17-19[0_25]
5-20	473-488	chemoattractant	event[18]|abstract[19]|object|substance[25]	new[18]|new[19]|new|new[25]	_	_
5-21	489-496	protein	event[18]|abstract[19]|substance[25]	new[18]|new[19]|new[25]	_	_
5-22	497-498	(	_	_	_	_
5-23	499-509	MCP-1/CCL2	abstract	new	_	_
5-24	510-511	)	_	_	_	_
5-25	512-516	from	_	_	_	_
5-26	517-524	adipose	abstract|object[28]|animal[29]	giv|giv[28]|new[29]	coref|coref|coref	6-4[0_29]|6-18|6-17[43_28]
5-27	525-531	tissue	object[28]|animal[29]	giv[28]|new[29]	_	_
5-28	532-543	macrophages	animal[29]	new[29]	_	_
5-29	544-545	,	_	_	_	_
5-30	546-549	and	_	_	_	_
5-31	550-555	these	abstract[30]	new[30]	coref	17-34[193_30]
5-32	556-563	factors	abstract[30]	new[30]	_	_
5-33	564-567	are	_	_	_	_
5-34	568-572	also	_	_	_	_
5-35	573-583	associated	_	_	_	_
5-36	584-586	to	_	_	_	_
5-37	587-590	the	abstract[31]	new[31]	_	_
5-38	591-599	presence	abstract[31]	new[31]	_	_
5-39	600-602	of	abstract[31]	new[31]	_	_
5-40	603-612	senescent	abstract[31]|object[32]	new[31]|new[32]	coref	12-16[109_32]
5-41	613-618	cells	abstract[31]|object[32]	new[31]|new[32]	_	_
5-42	619-620	(	_	_	_	_
5-43	621-629	p16INK4A	abstract	new	_	_
5-44	630-631	)	_	_	_	_
5-45	632-639	leading	_	_	_	_
5-46	640-642	to	_	_	_	_
5-47	643-659	immunosenescence	abstract	giv	coref	12-9
5-48	660-661	.	_	_	_	_

#Text=The exposure of macrophages to hormones , cytokines , chemokines , and fatty acids found within dysfunctional adipose tissue stimulates them to adopt a pro-inflammatory phenotype inflammation .
6-1	662-665	The	event[35]	new[35]	_	_
6-2	666-674	exposure	event[35]	new[35]	_	_
6-3	675-677	of	event[35]	new[35]	_	_
6-4	678-689	macrophages	event[35]|animal	new[35]|giv	ana	6-21
6-5	690-692	to	event[35]	new[35]	_	_
6-6	693-701	hormones	event[35]|substance	new[35]|new	_	_
6-7	702-703	,	event[35]	new[35]	_	_
6-8	704-713	cytokines	event[35]|abstract	new[35]|giv	coref	8-31[71_0]
6-9	714-715	,	event[35]	new[35]	_	_
6-10	716-726	chemokines	event[35]|abstract	new[35]|new	_	_
6-11	727-728	,	event[35]	new[35]	_	_
6-12	729-732	and	event[35]	new[35]	_	_
6-13	733-738	fatty	event[35]|abstract|substance[41]	new[35]|new|new[41]	_	_
6-14	739-744	acids	event[35]|substance[41]	new[35]|new[41]	_	_
6-15	745-750	found	event[35]|substance[41]	new[35]|new[41]	_	_
6-16	751-757	within	event[35]|substance[41]	new[35]|new[41]	_	_
6-17	758-771	dysfunctional	event[35]|substance[41]|object[43]	new[35]|new[41]|giv[43]	coref	7-2[48_43]
6-18	772-779	adipose	event[35]|substance[41]|abstract|object[43]	new[35]|new[41]|giv|giv[43]	coref	7-2
6-19	780-786	tissue	event[35]|substance[41]|object[43]	new[35]|new[41]|giv[43]	_	_
6-20	787-797	stimulates	_	_	_	_
6-21	798-802	them	animal	giv	coref	7-22[57_0]
6-22	803-805	to	_	_	_	_
6-23	806-811	adopt	_	_	_	_
6-24	812-813	a	abstract[45]	new[45]	_	_
6-25	814-830	pro-inflammatory	abstract[45]	new[45]	_	_
6-26	831-840	phenotype	abstract[45]	new[45]	_	_
6-27	841-853	inflammation	abstract	giv	coref	7-1[49_0]
6-28	854-855	.	_	_	_	_

#Text=Age-associated adipose tissue inflammation is related to the activation of the NFκB signaling pathway , with promotes a pro-inflammatory polarization of adipose tissue macrophages , independent from total adipose tissue mass .
7-1	856-870	Age-associated	abstract[49]	giv[49]	coref	16-29[169_49]
7-2	871-878	adipose	abstract|object[48]|abstract[49]	giv|giv[48]|giv[49]	coref|coref	7-22|7-22[56_48]
7-3	879-885	tissue	object[48]|abstract[49]	giv[48]|giv[49]	_	_
7-4	886-898	inflammation	abstract[49]	giv[49]	_	_
7-5	899-901	is	_	_	_	_
7-6	902-909	related	_	_	_	_
7-7	910-912	to	_	_	_	_
7-8	913-916	the	event[50]	new[50]	coref	12-12[0_50]
7-9	917-927	activation	event[50]	new[50]	_	_
7-10	928-930	of	event[50]	new[50]	_	_
7-11	931-934	the	event[50]|abstract[53]	new[50]|new[53]	_	_
7-12	935-939	NFκB	event[50]|abstract|abstract[53]	new[50]|new|new[53]	coref	14-43
7-13	940-949	signaling	event[50]|abstract|abstract[53]	new[50]|new|new[53]	coref	10-29[92_0]
7-14	950-957	pathway	event[50]|abstract[53]	new[50]|new[53]	_	_
7-15	958-959	,	_	_	_	_
7-16	960-964	with	_	_	_	_
7-17	965-973	promotes	_	_	_	_
7-18	974-975	a	abstract[54]	new[54]	coref	8-4[63_54]
7-19	976-992	pro-inflammatory	abstract[54]	new[54]	_	_
7-20	993-1005	polarization	abstract[54]	new[54]	_	_
7-21	1006-1008	of	abstract[54]	new[54]	_	_
7-22	1009-1016	adipose	abstract[54]|abstract|object[56]|animal[57]	new[54]|giv|giv[56]|giv[57]	coref|coref|coref	7-29|7-29[59_56]|12-2[0_57]
7-23	1017-1023	tissue	abstract[54]|object[56]|animal[57]	new[54]|giv[56]|giv[57]	_	_
7-24	1024-1035	macrophages	abstract[54]|animal[57]	new[54]|giv[57]	_	_
7-25	1036-1037	,	_	_	_	_
7-26	1038-1049	independent	_	_	_	_
7-27	1050-1054	from	_	_	_	_
7-28	1055-1060	total	abstract[60]	new[60]	_	_
7-29	1061-1068	adipose	abstract|object[59]|abstract[60]	giv|giv[59]|new[60]	coref|coref	8-34|8-34[73_59]
7-30	1069-1075	tissue	object[59]|abstract[60]	giv[59]|new[60]	_	_
7-31	1076-1080	mass	abstract[60]	new[60]	_	_
7-32	1081-1082	.	_	_	_	_

#Text=The stimulus for age-associated macrophage pro-inflammatory polarization can be associated with endoplasmic reticulum stress , which promotes a pro-inflammatory environment due to the release of IL-6 , MCP-1 , and TNF-α cytokines within adipose tissue .
8-1	1083-1086	The	abstract[61]	new[61]	_	_
8-2	1087-1095	stimulus	abstract[61]	new[61]	_	_
8-3	1096-1099	for	abstract[61]	new[61]	_	_
8-4	1100-1114	age-associated	abstract[61]|abstract[63]	new[61]|giv[63]	_	_
8-5	1115-1125	macrophage	abstract[61]|abstract|abstract[63]	new[61]|new|giv[63]	coref	9-14
8-6	1126-1142	pro-inflammatory	abstract[61]|abstract[63]	new[61]|giv[63]	_	_
8-7	1143-1155	polarization	abstract[61]|abstract[63]	new[61]|giv[63]	_	_
8-8	1156-1159	can	_	_	_	_
8-9	1160-1162	be	_	_	_	_
8-10	1163-1173	associated	_	_	_	_
8-11	1174-1178	with	_	_	_	_
8-12	1179-1190	endoplasmic	abstract[65]	new[65]	coref	11-6[0_65]
8-13	1191-1200	reticulum	abstract|abstract[65]	new|new[65]	_	_
8-14	1201-1207	stress	abstract[65]	new[65]	_	_
8-15	1208-1209	,	abstract[65]	new[65]	_	_
8-16	1210-1215	which	abstract[65]	new[65]	_	_
8-17	1216-1224	promotes	abstract[65]	new[65]	_	_
8-18	1225-1226	a	abstract[65]|abstract[66]	new[65]|new[66]	coref	16-4[161_66]
8-19	1227-1243	pro-inflammatory	abstract[65]|abstract[66]	new[65]|new[66]	_	_
8-20	1244-1255	environment	abstract[65]|abstract[66]	new[65]|new[66]	_	_
8-21	1256-1259	due	abstract[65]|abstract[66]	new[65]|new[66]	_	_
8-22	1260-1262	to	abstract[65]|abstract[66]	new[65]|new[66]	_	_
8-23	1263-1266	the	abstract[65]|abstract[66]|event[67]	new[65]|new[66]|new[67]	coref	13-7[128_67]
8-24	1267-1274	release	abstract[65]|abstract[66]|event[67]	new[65]|new[66]|new[67]	_	_
8-25	1275-1277	of	abstract[65]|abstract[66]|event[67]	new[65]|new[66]|new[67]	_	_
8-26	1278-1282	IL-6	abstract[65]|abstract[66]|event[67]|abstract	new[65]|new[66]|new[67]|giv	coref	14-32
8-27	1283-1284	,	abstract[65]|abstract[66]|event[67]	new[65]|new[66]|new[67]	_	_
8-28	1285-1290	MCP-1	abstract[65]|abstract[66]|event[67]|abstract	new[65]|new[66]|new[67]|new	_	_
8-29	1291-1292	,	abstract[65]|abstract[66]|event[67]	new[65]|new[66]|new[67]	_	_
8-30	1293-1296	and	abstract[65]|abstract[66]|event[67]	new[65]|new[66]|new[67]	_	_
8-31	1297-1302	TNF-α	abstract[65]|abstract[66]|event[67]|abstract|abstract[71]	new[65]|new[66]|new[67]|giv|giv[71]	coref	14-28
8-32	1303-1312	cytokines	abstract[65]|abstract[66]|event[67]|abstract[71]	new[65]|new[66]|new[67]|giv[71]	_	_
8-33	1313-1319	within	abstract[65]|abstract[66]|event[67]	new[65]|new[66]|new[67]	_	_
8-34	1320-1327	adipose	abstract[65]|abstract[66]|event[67]|abstract|object[73]	new[65]|new[66]|new[67]|giv|giv[73]	coref|coref	9-12|9-12[78_73]
8-35	1328-1334	tissue	abstract[65]|abstract[66]|event[67]|object[73]	new[65]|new[66]|new[67]|giv[73]	_	_
8-36	1335-1336	.	_	_	_	_

#Text=The decreased vascularization promoted by aging promotes local hypoxia and favors adipose tissue macrophage accumulation .
9-1	1337-1340	The	abstract[74]	new[74]	_	_
9-2	1341-1350	decreased	abstract[74]	new[74]	_	_
9-3	1351-1366	vascularization	abstract[74]	new[74]	_	_
9-4	1367-1375	promoted	abstract[74]	new[74]	_	_
9-5	1376-1378	by	abstract[74]	new[74]	_	_
9-6	1379-1384	aging	abstract[74]|abstract	new[74]|giv	coref	16-10
9-7	1385-1393	promotes	_	_	_	_
9-8	1394-1399	local	abstract[76]	new[76]	_	_
9-9	1400-1407	hypoxia	abstract[76]	new[76]	_	_
9-10	1408-1411	and	_	_	_	_
9-11	1412-1418	favors	_	_	_	_
9-12	1419-1426	adipose	abstract|object[78]|event[80]	giv|giv[78]|new[80]	coref|coref|coref	12-5|12-4[104_78]|13-1[125_80]
9-13	1427-1433	tissue	object[78]|event[80]	giv[78]|new[80]	_	_
9-14	1434-1444	macrophage	abstract|event[80]	giv|new[80]	coref	10-2
9-15	1445-1457	accumulation	event[80]	new[80]	_	_
9-16	1458-1459	.	_	_	_	_

#Text=The macrophage infiltration is perpetuated by a reduction in the mitochondrial cytochrome c oxidase subunit 5B ( COX5B ) component of complex IV within adipocytes , which inhibits lipolytic signaling and free-fatty acid mobilization and increases intracellular lipid storage .
10-1	1460-1463	The	abstract[82]	new[82]	_	_
10-2	1464-1474	macrophage	abstract|abstract[82]	giv|new[82]	_	_
10-3	1475-1487	infiltration	abstract[82]	new[82]	_	_
10-4	1488-1490	is	_	_	_	_
10-5	1491-1502	perpetuated	_	_	_	_
10-6	1503-1505	by	_	_	_	_
10-7	1506-1507	a	event[83]	new[83]	_	_
10-8	1508-1517	reduction	event[83]	new[83]	_	_
10-9	1518-1520	in	event[83]	new[83]	_	_
10-10	1521-1524	the	event[83]|abstract[89]	new[83]|new[89]	_	_
10-11	1525-1538	mitochondrial	event[83]|abstract[89]	new[83]|new[89]	_	_
10-12	1539-1549	cytochrome	event[83]|abstract|abstract[86]|abstract[87]|abstract[89]	new[83]|new|new[86]|new[87]|new[89]	_	_
10-13	1550-1551	c	event[83]|abstract|abstract[86]|abstract[87]|abstract[89]	new[83]|new|new[86]|new[87]|new[89]	_	_
10-14	1552-1559	oxidase	event[83]|abstract[86]|abstract[87]|abstract[89]	new[83]|new[86]|new[87]|new[89]	_	_
10-15	1560-1567	subunit	event[83]|abstract[87]|abstract[89]	new[83]|new[87]|new[89]	_	_
10-16	1568-1570	5B	event[83]|abstract[87]|abstract[89]	new[83]|new[87]|new[89]	_	_
10-17	1571-1572	(	event[83]|abstract[89]	new[83]|new[89]	_	_
10-18	1573-1578	COX5B	event[83]|substance|abstract[89]	new[83]|new|new[89]	_	_
10-19	1579-1580	)	event[83]|abstract[89]	new[83]|new[89]	_	_
10-20	1581-1590	component	event[83]|abstract[89]	new[83]|new[89]	_	_
10-21	1591-1593	of	event[83]|abstract[89]	new[83]|new[89]	_	_
10-22	1594-1601	complex	event[83]|abstract[89]|substance[90]	new[83]|new[89]|new[90]	_	_
10-23	1602-1604	IV	event[83]|abstract[89]|substance[90]	new[83]|new[89]|new[90]	_	_
10-24	1605-1611	within	event[83]	new[83]	_	_
10-25	1612-1622	adipocytes	event[83]|animal[91]	new[83]|new[91]	coref	11-4[0_91]
10-26	1623-1624	,	event[83]|animal[91]	new[83]|new[91]	_	_
10-27	1625-1630	which	event[83]|animal[91]	new[83]|new[91]	_	_
10-28	1631-1639	inhibits	event[83]|animal[91]	new[83]|new[91]	_	_
10-29	1640-1649	lipolytic	event[83]|animal[91]|abstract[92]	new[83]|new[91]|giv[92]	_	_
10-30	1650-1659	signaling	event[83]|animal[91]|abstract[92]	new[83]|new[91]|giv[92]	_	_
10-31	1660-1663	and	event[83]|animal[91]	new[83]|new[91]	_	_
10-32	1664-1674	free-fatty	event[83]|animal[91]|substance[93]|abstract[94]	new[83]|new[91]|new[93]|new[94]	_	_
10-33	1675-1679	acid	event[83]|animal[91]|substance[93]|abstract[94]	new[83]|new[91]|new[93]|new[94]	_	_
10-34	1680-1692	mobilization	event[83]|animal[91]|abstract[94]	new[83]|new[91]|new[94]	_	_
10-35	1693-1696	and	event[83]|animal[91]	new[83]|new[91]	_	_
10-36	1697-1706	increases	event[83]|animal[91]	new[83]|new[91]	_	_
10-37	1707-1720	intracellular	event[83]|animal[91]|abstract[96]	new[83]|new[91]|new[96]	_	_
10-38	1721-1726	lipid	event[83]|animal[91]|abstract|abstract[96]	new[83]|new[91]|new|new[96]	_	_
10-39	1727-1734	storage	event[83]|animal[91]|abstract[96]	new[83]|new[91]|new[96]	_	_
10-40	1735-1736	.	_	_	_	_

#Text=Hypertrophic expansion of adipocytes promotes stress signals , thereby contributing to immunometabolic dysfunction both locally and systemically .
11-1	1737-1749	Hypertrophic	event[97]	new[97]	_	_
11-2	1750-1759	expansion	event[97]	new[97]	_	_
11-3	1760-1762	of	event[97]	new[97]	_	_
11-4	1763-1773	adipocytes	event[97]|animal	new[97]|giv	coref	16-46
11-5	1774-1782	promotes	_	_	_	_
11-6	1783-1789	stress	abstract|abstract[100]	giv|new[100]	_	_
11-7	1790-1797	signals	abstract[100]	new[100]	_	_
11-8	1798-1799	,	_	_	_	_
11-9	1800-1807	thereby	_	_	_	_
11-10	1808-1820	contributing	_	_	_	_
11-11	1821-1823	to	_	_	_	_
11-12	1824-1839	immunometabolic	abstract[101]	giv[101]	coref	16-17[165_101]
11-13	1840-1851	dysfunction	abstract[101]	giv[101]	_	_
11-14	1852-1856	both	_	_	_	_
11-15	1857-1864	locally	_	_	_	_
11-16	1865-1868	and	_	_	_	_
11-17	1869-1881	systemically	_	_	_	_
11-18	1882-1883	.	_	_	_	_

#Text=Besides macrophages , dysfunctional adipose tissue can exacerbate immunosenescence by promoting activation and differentiation of immune cells such as B cells ( B lymphocytes ) , nautral killer ( NK ) lymphocytes , regulatory T cells , neutrophils , eosinophils , mast cells , dendritic cells .
12-1	1884-1891	Besides	_	_	_	_
12-2	1892-1903	macrophages	animal	giv	_	_
12-3	1904-1905	,	_	_	_	_
12-4	1906-1919	dysfunctional	object[104]	giv[104]	coref	14-21[141_104]
12-5	1920-1927	adipose	abstract|object[104]	giv|giv[104]	coref	14-23
12-6	1928-1934	tissue	object[104]	giv[104]	_	_
12-7	1935-1938	can	_	_	_	_
12-8	1939-1949	exacerbate	_	_	_	_
12-9	1950-1966	immunosenescence	abstract	giv	_	_
12-10	1967-1969	by	_	_	_	_
12-11	1970-1979	promoting	_	_	_	_
12-12	1980-1990	activation	event|event[107]	giv|new[107]	coref|coref	13-12[130_0]|13-12[131_107]
12-13	1991-1994	and	event[107]	new[107]	_	_
12-14	1995-2010	differentiation	event[107]|abstract[108]	new[107]|new[108]	coref	16-35[173_108]
12-15	2011-2013	of	event[107]|abstract[108]	new[107]|new[108]	_	_
12-16	2014-2020	immune	event[107]|abstract[108]|object[109]	new[107]|new[108]|giv[109]	coref	12-20[111_109]
12-17	2021-2026	cells	event[107]|abstract[108]|object[109]	new[107]|new[108]|giv[109]	_	_
12-18	2027-2031	such	event[107]|abstract[108]|object[109]	new[107]|new[108]|giv[109]	_	_
12-19	2032-2034	as	event[107]|abstract[108]|object[109]	new[107]|new[108]|giv[109]	_	_
12-20	2035-2036	B	event[107]|abstract[108]|object[109]|person|object[111]	new[107]|new[108]|giv[109]|new|giv[111]	coref|coref	12-23|12-34[118_111]
12-21	2037-2042	cells	event[107]|abstract[108]|object[109]|object[111]	new[107]|new[108]|giv[109]|giv[111]	_	_
12-22	2043-2044	(	_	_	_	_
12-23	2045-2046	B	person|plant[113]	giv|new[113]	coref	12-27[116_113]
12-24	2047-2058	lymphocytes	plant[113]	new[113]	_	_
12-25	2059-2060	)	_	_	_	_
12-26	2061-2062	,	_	_	_	_
12-27	2063-2070	nautral	person[114]|plant[116]	new[114]|giv[116]	coref	15-12[159_116]
12-28	2071-2077	killer	person[114]|plant[116]	new[114]|giv[116]	_	_
12-29	2078-2079	(	plant[116]	giv[116]	_	_
12-30	2080-2082	NK	abstract|plant[116]	new|giv[116]	coref	15-12
12-31	2083-2084	)	plant[116]	giv[116]	_	_
12-32	2085-2096	lymphocytes	plant[116]	giv[116]	_	_
12-33	2097-2098	,	_	_	_	_
12-34	2099-2109	regulatory	object[118]	giv[118]	coref	12-42[122_118]
12-35	2110-2111	T	person|object[118]	new|giv[118]	coref	15-9
12-36	2112-2117	cells	object[118]	giv[118]	_	_
12-37	2118-2119	,	_	_	_	_
12-38	2120-2131	neutrophils	abstract	new	coref	14-54
12-39	2132-2133	,	_	_	_	_
12-40	2134-2145	eosinophils	abstract	new	_	_
12-41	2146-2147	,	_	_	_	_
12-42	2148-2152	mast	object|object[122]	new|giv[122]	coref	12-45[123_122]
12-43	2153-2158	cells	object[122]	giv[122]	_	_
12-44	2159-2160	,	_	_	_	_
12-45	2161-2170	dendritic	object[123]	giv[123]	coref	14-4[135_123]
12-46	2171-2176	cells	object[123]	giv[123]	_	_
12-47	2177-2178	.	_	_	_	_

#Text=Immune cell accumulation in AT induces pro-inflammatory cytokine release leads to inflammasome activation and formation of crown-like structure .
13-1	2179-2185	Immune	place[124]|event[125]	new[124]|giv[125]	coref	14-48[0_124]
13-2	2186-2190	cell	place[124]|event[125]	new[124]|giv[125]	_	_
13-3	2191-2203	accumulation	event[125]	giv[125]	_	_
13-4	2204-2206	in	event[125]	giv[125]	_	_
13-5	2207-2209	AT	event[125]|time	giv[125]|new	_	_
13-6	2210-2217	induces	_	_	_	_
13-7	2218-2234	pro-inflammatory	event[128]	giv[128]	coref	14-39[0_128]
13-8	2235-2243	cytokine	abstract|event[128]	new|giv[128]	_	_
13-9	2244-2251	release	event[128]	giv[128]	_	_
13-10	2252-2257	leads	_	_	_	_
13-11	2258-2260	to	_	_	_	_
13-12	2261-2273	inflammasome	abstract|event[130]|event[131]	new|giv[130]|giv[131]	coref	14-43[150_130]
13-13	2274-2284	activation	event[130]|event[131]	giv[130]|giv[131]	_	_
13-14	2285-2288	and	event[131]	giv[131]	_	_
13-15	2289-2298	formation	event[131]|event[132]	giv[131]|new[132]	_	_
13-16	2299-2301	of	event[131]|event[132]	giv[131]|new[132]	_	_
13-17	2302-2312	crown-like	event[131]|event[132]|abstract[133]	giv[131]|new[132]|new[133]	_	_
13-18	2313-2322	structure	event[131]|event[132]|abstract[133]	giv[131]|new[132]|new[133]	_	_
13-19	2323-2324	.	_	_	_	_

#Text=The function of immune cells have been investigated in obesity , however some studies suggest that the pro-inflammatory microenvironment of aged murine adipose tissue , characterized by TNF-α , IFN-γ , IL-6 and prostaglandin E2 ( PGE2 ) release , could promote NFκB activation consequently modulate dendritic cell function , also can activate neutrophils .
14-1	2325-2328	The	abstract[134]	new[134]	coref	14-47[152_134]
14-2	2329-2337	function	abstract[134]	new[134]	_	_
14-3	2338-2340	of	abstract[134]	new[134]	_	_
14-4	2341-2347	immune	abstract[134]|object[135]	new[134]|giv[135]	coref	15-8[156_135]
14-5	2348-2353	cells	abstract[134]|object[135]	new[134]|giv[135]	_	_
14-6	2354-2358	have	_	_	_	_
14-7	2359-2363	been	_	_	_	_
14-8	2364-2376	investigated	_	_	_	_
14-9	2377-2379	in	_	_	_	_
14-10	2380-2387	obesity	abstract	new	_	_
14-11	2388-2389	,	_	_	_	_
14-12	2390-2397	however	_	_	_	_
14-13	2398-2402	some	abstract[137]	new[137]	_	_
14-14	2403-2410	studies	abstract[137]	new[137]	_	_
14-15	2411-2418	suggest	_	_	_	_
14-16	2419-2423	that	_	_	_	_
14-17	2424-2427	the	abstract[138]	new[138]	_	_
14-18	2428-2444	pro-inflammatory	abstract[138]	new[138]	_	_
14-19	2445-2461	microenvironment	abstract[138]	new[138]	_	_
14-20	2462-2464	of	abstract[138]	new[138]	_	_
14-21	2465-2469	aged	abstract[138]|object[141]	new[138]|giv[141]	coref	16-14[163_141]
14-22	2470-2476	murine	abstract[138]|plant|object[141]	new[138]|new|giv[141]	_	_
14-23	2477-2484	adipose	abstract[138]|abstract|object[141]	new[138]|giv|giv[141]	coref	16-29
14-24	2485-2491	tissue	abstract[138]|object[141]	new[138]|giv[141]	_	_
14-25	2492-2493	,	abstract[138]	new[138]	_	_
14-26	2494-2507	characterized	abstract[138]	new[138]	_	_
14-27	2508-2510	by	abstract[138]	new[138]	_	_
14-28	2511-2516	TNF-α	abstract[138]|abstract	new[138]|giv	_	_
14-29	2517-2518	,	abstract[138]	new[138]	_	_
14-30	2519-2524	IFN-γ	abstract[138]|abstract	new[138]|new	_	_
14-31	2525-2526	,	abstract[138]	new[138]	_	_
14-32	2527-2531	IL-6	abstract[138]|abstract	new[138]|giv	_	_
14-33	2532-2535	and	abstract[138]	new[138]	_	_
14-34	2536-2549	prostaglandin	abstract[138]|abstract|abstract[146]	new[138]|new|new[146]	appos	14-37[0_146]
14-35	2550-2552	E2	abstract[138]|abstract[146]	new[138]|new[146]	_	_
14-36	2553-2554	(	abstract[138]	new[138]	_	_
14-37	2555-2559	PGE2	abstract[138]|abstract	new[138]|giv	_	_
14-38	2560-2561	)	abstract[138]	new[138]	_	_
14-39	2562-2569	release	abstract[138]|event	new[138]|giv	_	_
14-40	2570-2571	,	_	_	_	_
14-41	2572-2577	could	_	_	_	_
14-42	2578-2585	promote	_	_	_	_
14-43	2586-2590	NFκB	abstract|event[150]	giv|giv[150]	_	_
14-44	2591-2601	activation	event[150]	giv[150]	_	_
14-45	2602-2614	consequently	_	_	_	_
14-46	2615-2623	modulate	_	_	_	_
14-47	2624-2633	dendritic	abstract[152]	giv[152]	_	_
14-48	2634-2638	cell	place|abstract[152]	giv|giv[152]	coref	16-35[172_0]
14-49	2639-2647	function	abstract[152]	giv[152]	_	_
14-50	2648-2649	,	_	_	_	_
14-51	2650-2654	also	_	_	_	_
14-52	2655-2658	can	_	_	_	_
14-53	2659-2667	activate	_	_	_	_
14-54	2668-2679	neutrophils	abstract	giv	_	_
14-55	2680-2681	.	_	_	_	_

#Text=Controversially , the pro-inflammatory state can inhibit regulatory T cells and NK lymphocytes , and also impair anti-inflammatory defense .
15-1	2682-2697	Controversially	_	_	_	_
15-2	2698-2699	,	_	_	_	_
15-3	2700-2703	the	abstract[154]	new[154]	_	_
15-4	2704-2720	pro-inflammatory	abstract[154]	new[154]	_	_
15-5	2721-2726	state	abstract[154]	new[154]	_	_
15-6	2727-2730	can	_	_	_	_
15-7	2731-2738	inhibit	_	_	_	_
15-8	2739-2749	regulatory	object[156]|object[157]	giv[156]|giv[157]	coref|coref	15-8[157_156]|16-48[177_157]
15-9	2750-2751	T	person|object[156]|object[157]	giv|giv[156]|giv[157]	_	_
15-10	2752-2757	cells	object[156]|object[157]	giv[156]|giv[157]	_	_
15-11	2758-2761	and	object[157]	giv[157]	_	_
15-12	2762-2764	NK	object[157]|abstract|plant[159]	giv[157]|giv|giv[159]	_	_
15-13	2765-2776	lymphocytes	object[157]|plant[159]	giv[157]|giv[159]	_	_
15-14	2777-2778	,	_	_	_	_
15-15	2779-2782	and	_	_	_	_
15-16	2783-2787	also	_	_	_	_
15-17	2788-2794	impair	_	_	_	_
15-18	2795-2812	anti-inflammatory	abstract[160]	new[160]	_	_
15-19	2813-2820	defense	abstract[160]	new[160]	_	_
15-20	2821-2822	.	_	_	_	_

#Text=Taken together , the chronic inflammatory environment promoted by aging can contribute to adipose tissue and skeletal muscle dysfunction and consequently leads to a feedback loop that perpetuates adipose inflammation and redistribution , impairs progenitor cell differentiation and leads to cellular dysfunction and death of adipocytes and neighboring cells such as skeletal muscle cells .
16-1	2823-2828	Taken	_	_	_	_
16-2	2829-2837	together	_	_	_	_
16-3	2838-2839	,	_	_	_	_
16-4	2840-2843	the	abstract[161]	giv[161]	_	_
16-5	2844-2851	chronic	abstract[161]	giv[161]	_	_
16-6	2852-2864	inflammatory	abstract[161]	giv[161]	_	_
16-7	2865-2876	environment	abstract[161]	giv[161]	_	_
16-8	2877-2885	promoted	abstract[161]	giv[161]	_	_
16-9	2886-2888	by	abstract[161]	giv[161]	_	_
16-10	2889-2894	aging	abstract[161]|abstract	giv[161]|giv	coref	17-57
16-11	2895-2898	can	_	_	_	_
16-12	2899-2909	contribute	_	_	_	_
16-13	2910-2912	to	_	_	_	_
16-14	2913-2920	adipose	object[163]	giv[163]	_	_
16-15	2921-2927	tissue	object[163]	giv[163]	_	_
16-16	2928-2931	and	_	_	_	_
16-17	2932-2940	skeletal	object[164]|abstract[165]	new[164]|giv[165]	coref|coref	16-41[174_165]|16-52[178_164]
16-18	2941-2947	muscle	object[164]|abstract[165]	new[164]|giv[165]	_	_
16-19	2948-2959	dysfunction	abstract[165]	giv[165]	_	_
16-20	2960-2963	and	_	_	_	_
16-21	2964-2976	consequently	_	_	_	_
16-22	2977-2982	leads	_	_	_	_
16-23	2983-2985	to	_	_	_	_
16-24	2986-2987	a	abstract[167]	new[167]	_	_
16-25	2988-2996	feedback	abstract|abstract[167]	new|new[167]	_	_
16-26	2997-3001	loop	abstract[167]	new[167]	_	_
16-27	3002-3006	that	abstract[167]	new[167]	_	_
16-28	3007-3018	perpetuates	abstract[167]	new[167]	_	_
16-29	3019-3026	adipose	abstract[167]|abstract|abstract[169]	new[167]|giv|giv[169]	coref	17-4[0_169]
16-30	3027-3039	inflammation	abstract[167]|abstract[169]	new[167]|giv[169]	_	_
16-31	3040-3043	and	abstract[167]	new[167]	_	_
16-32	3044-3058	redistribution	abstract[167]|abstract	new[167]|new	_	_
16-33	3059-3060	,	abstract[167]	new[167]	_	_
16-34	3061-3068	impairs	abstract[167]	new[167]	_	_
16-35	3069-3079	progenitor	abstract[167]|place|place[172]|abstract[173]	new[167]|new|giv[172]|giv[173]	_	_
16-36	3080-3084	cell	abstract[167]|place[172]|abstract[173]	new[167]|giv[172]|giv[173]	_	_
16-37	3085-3100	differentiation	abstract[167]|abstract[173]	new[167]|giv[173]	_	_
16-38	3101-3104	and	abstract[167]	new[167]	_	_
16-39	3105-3110	leads	abstract[167]	new[167]	_	_
16-40	3111-3113	to	_	_	_	_
16-41	3114-3122	cellular	abstract[174]	giv[174]	_	_
16-42	3123-3134	dysfunction	abstract[174]	giv[174]	_	_
16-43	3135-3138	and	_	_	_	_
16-44	3139-3144	death	event[175]	new[175]	_	_
16-45	3145-3147	of	event[175]	new[175]	_	_
16-46	3148-3158	adipocytes	event[175]|animal	new[175]|giv	_	_
16-47	3159-3162	and	_	_	_	_
16-48	3163-3174	neighboring	object[177]	giv[177]	coref	16-52[179_177]
16-49	3175-3180	cells	object[177]	giv[177]	_	_
16-50	3181-3185	such	object[177]	giv[177]	_	_
16-51	3186-3188	as	object[177]	giv[177]	_	_
16-52	3189-3197	skeletal	object[177]|object[178]|object[179]	giv[177]|giv[178]|giv[179]	coref	17-6[182_178]
16-53	3198-3204	muscle	object[177]|object[178]|object[179]	giv[177]|giv[178]|giv[179]	_	_
16-54	3205-3210	cells	object[177]|object[179]	giv[177]|giv[179]	_	_
16-55	3211-3212	.	_	_	_	_

#Text=The effects of inflammation on skeletal muscle is also related to the effects of inflammatory mediators on muscle protein metabolism ( muscle protein breakdown and synthesis ) ; however , way in which the inflammatory factors can induce muscle wasting and the extent to which they do so remains a largely unexplored area of research in aging .
17-1	3213-3216	The	abstract[180]	new[180]	_	_
17-2	3217-3224	effects	abstract[180]	new[180]	_	_
17-3	3225-3227	of	abstract[180]	new[180]	_	_
17-4	3228-3240	inflammation	abstract[180]|abstract	new[180]|giv	_	_
17-5	3241-3243	on	abstract[180]	new[180]	_	_
17-6	3244-3252	skeletal	abstract[180]|object[182]	new[180]|giv[182]	coref	17-18[0_182]
17-7	3253-3259	muscle	abstract[180]|object[182]	new[180]|giv[182]	_	_
17-8	3260-3262	is	_	_	_	_
17-9	3263-3267	also	_	_	_	_
17-10	3268-3275	related	_	_	_	_
17-11	3276-3278	to	_	_	_	_
17-12	3279-3282	the	abstract[183]	new[183]	_	_
17-13	3283-3290	effects	abstract[183]	new[183]	_	_
17-14	3291-3293	of	abstract[183]	new[183]	_	_
17-15	3294-3306	inflammatory	abstract[183]|person[184]	new[183]|new[184]	ana	17-46[0_184]
17-16	3307-3316	mediators	abstract[183]|person[184]	new[183]|new[184]	_	_
17-17	3317-3319	on	abstract[183]	new[183]	_	_
17-18	3320-3326	muscle	abstract[183]|object|abstract[187]	new[183]|giv|new[187]	coref|appos	17-22|17-26[0_187]
17-19	3327-3334	protein	abstract[183]|substance|abstract[187]	new[183]|giv|new[187]	coref	17-22[189_0]
17-20	3335-3345	metabolism	abstract[183]|abstract[187]	new[183]|new[187]	_	_
17-21	3346-3347	(	_	_	_	_
17-22	3348-3354	muscle	object|substance[189]|event[190]	giv|giv[189]|new[190]	coref	17-39
17-23	3355-3362	protein	substance[189]|event[190]	giv[189]|new[190]	_	_
17-24	3363-3372	breakdown	event[190]	new[190]	_	_
17-25	3373-3376	and	_	_	_	_
17-26	3377-3386	synthesis	abstract	giv	_	_
17-27	3387-3388	)	_	_	_	_
17-28	3389-3390	;	_	_	_	_
17-29	3391-3398	however	_	_	_	_
17-30	3399-3400	,	_	_	_	_
17-31	3401-3404	way	abstract[192]	new[192]	_	_
17-32	3405-3407	in	abstract[192]	new[192]	_	_
17-33	3408-3413	which	abstract[192]	new[192]	_	_
17-34	3414-3417	the	abstract[192]|abstract[193]	new[192]|giv[193]	_	_
17-35	3418-3430	inflammatory	abstract[192]|abstract[193]	new[192]|giv[193]	_	_
17-36	3431-3438	factors	abstract[192]|abstract[193]	new[192]|giv[193]	_	_
17-37	3439-3442	can	abstract[192]	new[192]	_	_
17-38	3443-3449	induce	abstract[192]	new[192]	_	_
17-39	3450-3456	muscle	abstract[192]|object|event[195]	new[192]|giv|new[195]	_	_
17-40	3457-3464	wasting	abstract[192]|event[195]	new[192]|new[195]	_	_
17-41	3465-3468	and	abstract[192]	new[192]	_	_
17-42	3469-3472	the	abstract[192]|abstract[196]	new[192]|new[196]	_	_
17-43	3473-3479	extent	abstract[192]|abstract[196]	new[192]|new[196]	_	_
17-44	3480-3482	to	abstract[192]|abstract[196]	new[192]|new[196]	_	_
17-45	3483-3488	which	abstract[192]|abstract[196]	new[192]|new[196]	_	_
17-46	3489-3493	they	abstract[192]|abstract[196]|person	new[192]|new[196]|giv	_	_
17-47	3494-3496	do	abstract[192]|abstract[196]	new[192]|new[196]	_	_
17-48	3497-3499	so	abstract[192]|abstract[196]	new[192]|new[196]	_	_
17-49	3500-3507	remains	_	_	_	_
17-50	3508-3509	a	abstract[198]	new[198]	_	_
17-51	3510-3517	largely	abstract[198]	new[198]	_	_
17-52	3518-3528	unexplored	abstract[198]	new[198]	_	_
17-53	3529-3533	area	abstract[198]	new[198]	_	_
17-54	3534-3536	of	abstract[198]	new[198]	_	_
17-55	3537-3545	research	abstract[198]|abstract	new[198]|new	_	_
17-56	3546-3548	in	_	_	_	_
17-57	3549-3554	aging	abstract	giv	_	_
17-58	3555-3556	.	_	_	_	_
